134 related articles for article (PubMed ID: 24021784)
21. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
[TBL] [Abstract][Full Text] [Related]
22. The study on the role of hepatitis B virus X protein and apoptosis in HBV intrauterine infection.
Bai G; Wang Y; Zhang L; Tang Y; Fu F
Arch Gynecol Obstet; 2012 Apr; 285(4):943-9. PubMed ID: 21986716
[TBL] [Abstract][Full Text] [Related]
23. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
[TBL] [Abstract][Full Text] [Related]
24. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
You J; Sriplung H; Chongsuvivatwong V; Geater A; Zhuang L; Huang JH; Chen HY; Yu L; Tang BZ
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881
[TBL] [Abstract][Full Text] [Related]
25. [Comparative study of the expression of IGF-2 and HBxAg in human hepatocellular carcinoma and liver cirrhosis].
Zhang JF; Liu YF; Su Q
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):282-4. PubMed ID: 7874760
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistochemical study on X antigen of HBV (HBxAg) in primary hepatic carcinoma].
Wang WL
Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):331-3. PubMed ID: 1337887
[TBL] [Abstract][Full Text] [Related]
27. [Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma and their significance in clinical settings].
Tong GD; Zhou DQ; He JS; Xiao CL; Liu XL; Zhou XZ; Zhang X; Xing YF; Lü P; Feitelson MA
Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):828-32. PubMed ID: 18073065
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis B virus (HBV) mutation in enhancer I (HBV Enh I)/X-promoter and the relationship between chronic HBV-related disease spectrum].
Deng HH; Guan YJ; Lei CL; Xu M; Hu FY; Cheng J; Li YP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):25-7. PubMed ID: 22919746
[TBL] [Abstract][Full Text] [Related]
29. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
Seo JH; Kim KW; Murakami S; Park BC
J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091
[TBL] [Abstract][Full Text] [Related]
30. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
31. [Changes in HBsAg titer and HBV DNA load and their correlation in patients with chronic hepatitis B and HBV-related liver cirrhosis].
Yu X; Guo R; Ke S; Huang Q; Lin C; Lin Z; Chen S; Li J; Yang P; Su Z
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):682-6. PubMed ID: 26018262
[TBL] [Abstract][Full Text] [Related]
32. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma.
Liu J; Lian Z; Han S; Waye MM; Wang H; Wu MC; Wu K; Ding J; Arbuthnot P; Kew M; Fan D; Feitelson MA
Oncogene; 2006 Feb; 25(7):1008-17. PubMed ID: 16247464
[TBL] [Abstract][Full Text] [Related]
35. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
36. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma.
Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA
Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253
[TBL] [Abstract][Full Text] [Related]
37. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.
Zhang X; Dong N; Yin L; Cai N; Ma H; You J; Zhang H; Wang H; He R; Ye L
J Med Virol; 2005 Nov; 77(3):374-81. PubMed ID: 16173017
[TBL] [Abstract][Full Text] [Related]
39. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
